Tokyo, Aug. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058768) titled 'Switch from cinacalcet to evocalcet in haemodialysis patients in the real world' on Aug. 18.
Study Type:
Observational
Primary Sponsor:
Institute - Patient Driven Academic League
Condition:
Condition - Japanese Dialysis Patients with CKD-MBD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - In dialysis patients with CKD-MBD who do not achieve a sufficient response to cinacalcet, a calcimimetic, evaluate in routine clinical practice the changes in CKD-MBD management after switching to the new calcimimetic evocalcet.
Basic objectives2 - Others
Eligibility:
Age-lower ...